Vincerx Pharma (VINC) Stock Chart & Stock Price History $0.04 -0.01 (-15.14%) As of 07/3/2025 12:54 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vincerx Pharma Stock Price Performance The Vincerx Pharma (VINC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.75%, with a year-to-date return of -99.28%. In the past month, the stock has decreased 36.39%, reflecting recent market activity. As of the latest close, Vincerx Pharma traded at $0.04 with a market cap of $199 thousand and volume of 20,532 shares. Receive VINC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.41%1 Month Performance-36.39%3 Month Performance-93.70%Year-To-Date Performance-99.28%1 Year Performance-99.75% VINC Stock Chart for Saturday, July, 5, 2025 VINC Chart by TradingView Vincerx Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.04$0.04$0.05$0.0420,532 shs$199,000.0007/03/2025$0.04$0.04-15.14%$0.05$0.0420,532 shs$199,000.0007/02/2025$0.05$0.04-0.22%$0.05$0.04103,711 shs$235,000.0007/01/2025$0.04$0.05+2.27%$0.05$0.0426,089 shs$236,000.0006/30/2025$0.05$0.04-12.00%$0.05$0.04598,287 shs$230,000.0006/27/2025$0.06$0.05-9.09%$0.06$0.05173,743 shs$262,000.0006/26/2025$0.05$0.06+10.66%$0.06$0.05281,778 shs$288,000.0006/25/2025$0.06$0.05-9.64%$0.05$0.05150,230 shs$260,000.0006/24/2025$0.05$0.06+10.00%$0.06$0.0533,397 shs$288,000.0006/23/2025$0.05$0.05-2.91%$0.06$0.0518,853 shs$262,000.00 Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.05$0.05-4.63%$0.06$0.0550,543 shs$270,000.0006/19/2025$0.05$0.05$0.05$0.0518,744 shs$283,000.0006/18/2025$0.05$0.05+4.85%$0.05$0.0518,744 shs$283,000.0006/17/2025$0.05$0.05+1.18%$0.05$0.0518,917 shs$270,000.0006/16/2025$0.06$0.05-7.45%$0.06$0.0531,209 shs$266,000.0006/13/2025$0.06$0.06-6.46%$0.06$0.0567,363 shs$288,000.0006/12/2025$0.05$0.06+21.24%$0.06$0.05327,359 shs$308,000.0006/11/2025$0.05$0.05-6.73%$0.06$0.0531,721 shs$254,000.0006/10/2025$0.05$0.05+0.78%$0.05$0.0542,197 shs$272,000.0006/09/2025$0.06$0.05-9.47%$0.06$0.05140,479 shs$270,000.0006/06/2025$0.06$0.06-4.84%$0.06$0.0573,815 shs$298,000.0006/05/2025$0.06$0.06-0.50%$0.07$0.0569,060 shs$314,000.0006/04/2025$0.05$0.06+22.86%$0.06$0.04231,644 shs$315,000.00 Related Companies HEPA Stock Chart SRNE Stock Chart REVB Stock Chart BIOR Stock Chart VIRX Stock Chart ATXI Stock Chart SYRS Stock Chart NCNA Stock Chart BPTSY Stock Chart VRPX Stock Chart Receive VINC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VINC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
